Trials / Terminated
TerminatedNCT04935411
Russian Registry of Patients With nAMD
Russian Registry of Patients With Neovascular Age-Related Macular Degeneration (nAMD)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,665 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A three-year, non-randomized, observational, multicenter prospective nAMD study - patient registry.
Detailed description
The registry is a structured system which uses observational study methods for systematic collection of data on health condition in the specific patient population. Real world clinical practice data will be collected. Patients will not undergo any additional examinations or procedures that are outside of the standard clinical practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | nAMD | patients diagnosed with Neovascular Age-Related Macular Degeneration |
Timeline
- Start date
- 2020-12-20
- Primary completion
- 2022-12-05
- Completion
- 2022-12-05
- First posted
- 2021-06-23
- Last updated
- 2025-08-07
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04935411. Inclusion in this directory is not an endorsement.